Cellmover

Cellmover is a dynamic biotechnology research company dedicated to pioneering innovative strategies in immunotherapy. With a focus on enhancing immune cell activation, Cellmover is committed to developing cutting-edge solutions for therapeutic applications. The company's research efforts include advancing the delivery of therapeutic modules into immune cells and improving lymphocyte homing to tumors, aiming to revolutionize treatment methodologies.

Located at Melkeveien 39, Vestre Aker, Oslo 0779, NO, Cellmover operates as a privately held entity established in 2015. The company is driven by a mission to translate advanced research into tangible clinical benefits. Cellmover continues to push the boundaries of biotechnology, contributing significantly to the progress of immunotherapy.

Cellmover is poised for continued growth and innovation in the biotechnology sector. We invite the management team at Cellmover to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work and expand their commercial reach.